Cargando…
Apolipoprotein Eε4: A Biomarker for Executive Dysfunction among Parkinson's Disease Patients with Mild Cognitive Impairment
Background: Cognitive impairment is prevalent in Parkinson's disease (PD), affecting 15–20% of patients at diagnosis. α-synuclein expression and genetic polymorphisms of Apolipoprotein E (ApoE) have been associated with the presence of cognitive impairment in PD although data have been inconsis...
Autores principales: | Samat, Nor A., Abdul Murad, Nor A., Mohamad, Khairiyah, Abdul Razak, Mohd R., Mohamed Ibrahim, Norlinah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742342/ https://www.ncbi.nlm.nih.gov/pubmed/29326545 http://dx.doi.org/10.3389/fnins.2017.00712 |
Ejemplares similares
-
MicroRNAs and Target Genes As Biomarkers for the Diagnosis of Early Onset of Parkinson Disease
por: Arshad, Ahmad R., et al.
Publicado: (2017) -
Editorial: Genetic and molecular diversity in Parkinson's disease
por: Abdul Murad, Nor Azian, et al.
Publicado: (2022) -
The multifaceted impact of structured training program on persons with Parkinson disease and their adult caregiver: A protocol for a systematic review
por: Gopala Krishna Pillai, Sharmila, et al.
Publicado: (2023) -
On the analysis of EEG power, frequency and asymmetry in Parkinson’s disease during emotion processing
por: Yuvaraj, Rajamanickam, et al.
Publicado: (2014) -
Apolipoprotein E ε4 Specifically Modulates the Hippocampus Functional Connectivity Network in Patients With Amnestic Mild Cognitive Impairment
por: Zhu, Lin, et al.
Publicado: (2018)